Fifth Third Bancorp
IBRX icon

Fifth Third Bancorp’s ImmunityBio IBRX Stock Holding History

Fifth Third Bancorp’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.7K Buy
7,500
+7,284
+3,372% +$55.1K ﹤0.01% 3128
2026
Q1 		$1.66K Buy
+216
New +$1.48K ﹤0.01% 4062
2021
Q1 		– Sell
-7,300
Closed -$97K – 2449
2020
Q4 		$97K Hold
7,300
– – ﹤0.01% 1161
2020
Q3 		$51K Buy
+7,300
New +$72.8K ﹤0.01% 1322

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fifth Third Bancorp's IBRX Position: Q2 2026 in Review

Fifth Third Bancorp increased its ImmunityBio (IBRX) stake by 3,372% in Q2 2026, buying an estimated $55.1K and bringing the position to 7,500 shares worth $65.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3128.

Fifth Third Bancorp first reported a position in IBRX in Q3 2020 and has held it in 4 quarters since. The position peaked at $97K in Q4 2020. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Fifth Third Bancorp held 7,500 shares of ImmunityBio worth $65.7K as of Q2 2026.
  • Fifth Third Bancorp bought 7,284 ImmunityBio shares in Q2 2026, an estimated $55.1K.
  • ImmunityBio made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3128 holding.
  • Fifth Third Bancorp first reported a position in ImmunityBio in Q3 2020 and has held it in 4 quarters since.
  • Fifth Third Bancorp's ImmunityBio position peaked at $97K in Q4 2020.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.